Pain News and Research

Latest Pain News and Research

Cannabis-based medications prove effective in relieving pain

Cannabis-based medications have been proved to relieve pain. This is the conclusion drawn by Franjo Grotenhermen and Kirsten Müller-Vahl in issue 29-30 of Deutsches Ärzteblatt International.

7 Aug 2012

NYUCN professor to investigate efficacy of Acu/Moxa in managing irritable bowel syndrome

New York University College of Nursing's (NYUCN) Joyce K. Anastasi, PhD, DrNP, FAAN, LAc., the Independence Foundation Endowed Professor and Founding Director of the Division of Special Studies in Symptom Management at NYUCN has been awarded a $2.5 million four-year National Institutes of Health (NIH) grant for the study of "Symptom management for irritable bowel syndrome (IBS) constipation".

7 Aug 2012

The Patient Recruiting Agency announces enrollment for research study of women with IC/BPS

The Patient Recruiting Agency announces recruitment for a research study of female patients with Interstitial Cystitis/Bladder Pain Syndrome (IC/BPS).

7 Aug 2012

Heartburn can cause cancer: New guide for patients

Every day, an estimated 25 million American adults suffer from heartburn. Some experts believe that 40 percent of adults experience heartburn every month. Despite these staggering statistics, few people understand the real risk that Heartburn can cause Cancer.

6 Aug 2012

Cardiovascular risk present across chronic rheumatic diseases

Patients across the spectrum of rheumatic diseases, not just those with rheumatoid arthritis, have a significantly increased prevalence of cardiovascular risk factors compared with the general population, the results of a Dutch study indicate.

6 Aug 2012

Early CT ‘definitive’ for subarachnoid hemorrhage diagnosis

Cerebrospinal fluid analysis is only necessary for patients with thunderclap headache and a negative computed tomography scan if they undergo imaging more than 6 hours after headache onset, research suggests.

6 Aug 2012

Qualitest confirms launch of generic Singulair Tablets for asthma and allergic rhinitis

Qualitest Pharmaceuticals today confirmed that it has launched a generic version of Singulair (montelukast sodium) Tablets and Chewable Tablets, following the expiration of the last patent that provides Merck U.S. market exclusivity. Qualitest will begin shipping the product immediately. Montelukast Sodium Tablets are labeled for use in treating symptoms of asthma and allergic rhinitis.

6 Aug 2012

Medical devices for diabetic peripheral neuropathy: an interview with Dr. Shai Gozani, CEO of NeuroMetrix

About two years ago NeuroMetrix changed their focus from general purpose devices, used to perform nerve conduction tests, to devices designed to specifically address diabetic peripheral neuropathy or DPN.

6 Aug 2012

Montefiore launches first fellowship program in Women's Physical Medicine and Rehabilitation

Montefiore Medical Center has launched the nation's first fellowship program in Women's Physical Medicine and Rehabilitation (WPM&R), and established a new clinical program in this specialty.

6 Aug 2012

First generic versions of Singulair receive FDA approval for treatment of asthma, allergies

The U.S. Food and Drug Administration today approved the first generic versions of Singulair (montelukast sodium) for use in adults and children to control asthma symptoms and to help relieve symptoms of indoor and outdoor allergies.

6 Aug 2012

Sanofi-aventis receives FDA approval for Zaltrap to treat colorectal cancer

The U.S. Food and Drug Administration today approved Zaltrap (ziv-aflibercept) for use in combination with a FOLFIRI (folinic acid, fluorouracil and irinotecan) chemotherapy regimen to treat adults with colorectal cancer.

6 Aug 2012

'Fight' between bacteria in the intestines linked to chronic disease

Results from a study conducted at Georgia State University suggest that a "fight" between bacteria normally living in the intestines and the immune system, kicked off by another type of bacteria, may be linked to two types of chronic disease.

3 Aug 2012

Some small businesses brace for health law hardships

The Wall Street Journal reports on the impact the health law could have on restaurants and retailers, while other news outlets explore reverberations of the Supreme Court decision making the expansion of Medicaid effectively optional.

3 Aug 2012

Missouri Supreme Court strikes down cap on medical malpractice damages

Missouri's Supreme Court has ruled that a 20-year-old, $350,000 cap on noneconomic medical malpractice damages -- pain and suffering -- takes away a citizen's right to trial by jury and is unconstitutional.

3 Aug 2012

U.S. appeals court blocks Arizona's 20-week abortion ban

A federal appeals court on Wednesday blocked an Arizona law banning abortions after 20 weeks of pregnancy as it considers the case. The law was upheld by a trial judge Monday and was set to take effect Thursday.

3 Aug 2012

Advice to stay active promotes recovery in patients with low back pain

For workers on medical leave because of low back pain, giving advice to stay active increases the chances of returning to work, reports a study in the August 1 issue of Spine.

3 Aug 2012

Viewpoints: Orszag on CAP cost-control proposals; High-tech and health costs

The Center for American Progress proposals thus wisely recognize that there is no single strategy to continue the recent progress in slowing the growth in health-care costs. In contrast, the Republican budget plan put forward by Representative Paul Ryan of Wisconsin seems based on a belief that all that's needed is to shift risks: from Medicare to beneficiaries through a premium-support program, and from the federal government to state governments by turning Medicaid into block grants.

3 Aug 2012

House rejects bill limiting DC abortions

The measure, which did not get the two-thirds majority needed under special procedural rules, would have banned abortion in the District after 20 weeks of pregnancy based on a disputed notion that fetus at that point can feel pain.

2 Aug 2012

BMC to implement and evaluate opioid risk reduction model in primary care settings

Researchers at Boston Medical Center (BMC) have received a $2.67 million grant from the National Institute on Drug Abuse (NIDA) to implement and evaluate a new model of care in primary care settings aimed at decreasing the misuse of and addiction to opioids among patients with chronic pain.

2 Aug 2012

FDA clearance - scoliosis - DePuy synthes spine

DePuy Synthes Spine announced it has received 510(k) clearance from the U.S. Food and Drug Administration (FDA) for use of its EXPEDIUM®, VIPER®, and VIPER®2 Spine Systems on patients with adolescent idiopathic scoliosis (AIS), an abnormal curvature of the spine that typically affects children between the ages of 10 and 18.(1) This expands the scoliosis indication for the pedicle screw systems, which now are indicated for both adolescents and adults.

2 Aug 2012

Pain News and Research

Latest Pain News and Research

Cannabis-based medications prove effective in relieving pain

NYUCN professor to investigate efficacy of Acu/Moxa in managing irritable bowel syndrome

The Patient Recruiting Agency announces enrollment for research study of women with IC/BPS

Heartburn can cause cancer: New guide for patients

Cardiovascular risk present across chronic rheumatic diseases

Early CT ‘definitive’ for subarachnoid hemorrhage diagnosis

Qualitest confirms launch of generic Singulair Tablets for asthma and allergic rhinitis

Medical devices for diabetic peripheral neuropathy: an interview with Dr. Shai Gozani, CEO of NeuroMetrix

Montefiore launches first fellowship program in Women's Physical Medicine and Rehabilitation

First generic versions of Singulair receive FDA approval for treatment of asthma, allergies

Sanofi-aventis receives FDA approval for Zaltrap to treat colorectal cancer

'Fight' between bacteria in the intestines linked to chronic disease

Some small businesses brace for health law hardships

Missouri Supreme Court strikes down cap on medical malpractice damages

U.S. appeals court blocks Arizona's 20-week abortion ban

Advice to stay active promotes recovery in patients with low back pain

Viewpoints: Orszag on CAP cost-control proposals; High-tech and health costs

House rejects bill limiting DC abortions

BMC to implement and evaluate opioid risk reduction model in primary care settings

FDA clearance - scoliosis - DePuy synthes spine

Industry Focus eBook - Forensics & toxicology (2nd edition) eBook

How GLP‑1 Agonists Are Shaping the Future of Obesity Treatment With Dr Bryony Henderson

Flow chemistry, AI, and NMR: A next-gen approach to scalable API production

Digital pathology and the PathoVerse: A conversation with Dr. Singh

Pain News and Research

Latest Pain News and Research

Industry Focus eBook - Forensics & toxicology (2nd edition) eBook

How GLP‑1 Agonists Are Shaping the Future of Obesity Treatment With Dr Bryony Henderson

Flow chemistry, AI, and NMR: A next-gen approach to scalable API production

Digital pathology and the PathoVerse: A conversation with Dr. Singh

Newsletters you may be interested in